Objective: To provide clarification on the distinction between cognitive screening, cognitive
testing, and neuropsychological assessment and highlight practical implications. Method …

For both children and adults with neurological, neurodevelopmental, medical, or psychiatric
disorders, neuropsychological assessment can be a valuable tool in determining diagnosis …

Background Cortical and subcortical cognitive impairments have been found in dementia
with Lewy bodies (DLB). Roughly, they comprise visuoconstructive and executive …

Objective We aimed to determine the association between striatal dopaminergic depletion,
cerebral β‐amyloid deposition, and cognitive dysfunction in Lewy body disease (LBD) …

Abstract Lewy Body Dementia is the second most frequent neurodegenerative illness
proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly …

Dementia with Lewy bodies (DLB), the second most common neurodegenerative dementia,
is characterized by cognitive decline, fluctuation of cognition and alertness, visual …

The selection of appropriate outcome measures is fundamental to the design of any
successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most …

El aumento progresivo de la esperanza de vida ha impuesto nuevos desafíos en el
abordaje de las patologías que sufren los adultos mayores. Las demencias son unas de las …

To evaluate the implication of 18F-fluorodeoxyglucose (FDG)-and dopamine transporter
(DAT)-positron emission tomography (PET) in the diagnosis and clinical symptoms of …

Dementia with Lewy bodies (DLB) is a major neurocognitive disorder (MNCD) that is
primarily characterized by motor, cognitive, and behavioral symptoms. Although not …